Co-Diagnostics, Inc.
CODX
$1.55
$0.021.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -133.39% | 39.29% | -1.72% | 19.10% | 24.84% |
| Total Depreciation and Amortization | -25.06% | -23.86% | -13.86% | -15.18% | 14.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,587.60% | -43.42% | -82.33% | -117.35% | -91.52% |
| Change in Net Operating Assets | -94.67% | -163.31% | -480.43% | -155.73% | 48.48% |
| Cash from Operations | 24.68% | 18.33% | -59.25% | -3.00% | -72.25% |
| Capital Expenditure | -80.82% | 56.94% | -306.80% | 77.16% | 84.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -158.26% | -48.19% | 543.72% | -56.38% | -96.64% |
| Cash from Investing | -223.83% | -47.82% | 522.95% | -55.87% | -97.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6,607.80% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,607.80% | -- | -- | -- | 165.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.61% | 110.74% | 199.69% | -112.63% | -268.08% |